KNOWLEDGE CENTRE · ARTICLE

What to Know About Probiotic Use in Children

Infants' and children's gut microbiota develops differently from adults'. Delivery mode, breast milk, complementary foods and daily diet are part of this process.

The Enteromax family includes formats such as drops and sachets for children. According to its approved directions, Enteromax Drops can be used from the newborn period. Enteromax Drops and Sachets safely support little ones' digestive comfort and relief from gas. Each product's own packaging guides its age group and daily amount.

3 scientific sourcesGo to references

The short answer

Some probiotic strains have been investigated clinically in children for specific gastrointestinal conditions. Strain identity, age suitability and dose are therefore assessed together.

When assessing a probiotic for a child, consider:

  • suitability for the age group,
  • strain identity,
  • dose,
  • purpose of use,
  • safety data

in particular.

Although daily probiotic use is often well tolerated in healthy children, serious illness or immunosuppression requires professional assessment.

Is children's gut microbiota the same as adults'?

It is a developing ecosystem with its own characteristics, shaped from birth and continuing to change throughout childhood.

Early life may be influenced by:

  • delivery mode,
  • breastfeeding or other feeding methods,
  • antibiotic use,
  • environmental contacts,
  • dietary variety

and other factors.

Infant and childhood microbiota is a distinct ecosystem with its own developmental dynamics.

In which areas are probiotics studied in children?

Research has investigated probiotics for:

  • acute gastrointestinal infections,
  • antibiotic-associated diarrhoea,
  • specific intestinal functions,
  • early-life microbiota development

among other areas.

Guidelines emphasise strain-specific efficacy, making the investigated strain's identity particularly important.

Are strains in Enteromax included in children's research?

Yes. Some have been studied directly or at species level in childhood and early life.

Direct childhood clinical data for LRa05

Lacticaseibacillus rhamnosus LRa05 has been assessed in a randomised controlled trial in children with acute watery diarrhoea.[1]

The trial reported favourable findings for diarrhoea duration and some clinical outcomes with LRa05.

The direct strain match makes LRa05's childhood research scientifically meaningful. The study concerned acute watery diarrhoea; necessary medical treatment remains under healthcare professional supervision.

Species-level infant data for B. infantis

Studies of M-63 and LMG11588 in healthy infants provide human data on B. longum subsp. infantis in early-life microbiota.[2][3] Enteromax Drops includes BIO5478 of this subspecies.

What should be considered when choosing a childhood probiotic?

Age suitability

The label and current directions should suit the child's age group.

Strain identity

Seeing the species and, where possible, the strain code improves scientific traceability.

CFU count

Live microorganism count contributes to quality assessment alongside strain identity, formulation and purpose.

Product form

Drops, sachets and capsules may differ according to age and ease of use.

Evidence

Has the strain actually been studied in children, or are only adult data available?

This question matters.

Should children use probiotics every day?

Use is planned by considering age, diet, clinical condition, strain and product age suitability together.

The relevance of use may vary according to:

  • diet,
  • age,
  • gastrointestinal condition,
  • antibiotic use,
  • product purpose

among other factors.

Are probiotics considered during antibiotic use in children?

Some paediatric strains have been studied for antibiotic-associated diarrhoea.

Clinical evidence for strain and dose matters. Antibiotics continue at the prescribed dose and duration; probiotics are considered supportive.

What deserves attention in childhood probiotic selection?

Core criteria are age suitability, clear strain identity, daily amount and format. Many probiotics are well tolerated in healthy children.

For newborn and child products, packaging age ranges and directions guide use. Premature infants, severe immunosuppression or special medical monitoring require physician assessment.

Enteromax Drops and Sachets provide options for different needs; current labels guide the appropriate format.

Conclusion

In summary: Childhood microbiota develops with age; strain identity, age suitability, dose and purpose all matter.

What this means in daily life: Age-appropriate drops or sachets and clear strain information help families make informed assessments.

What research shows: The paediatric context of strain and dose should be maintained; serious symptoms or specific health conditions require professional advice.

Explore more: To learn more about the early-life ecosystem, read How Does the Gut Microbiota Develop in Infants?

Frequently Asked Questions

Can children be given probiotics?

Age-appropriate products and certain strains can be used; selection should reflect strain, dose, age and purpose.

Are children's probiotics different from adult probiotics?

Formula, dose and method can differ. Suitability for the child's age group matters most.

Why do CFU and strain information matter in children's probiotics?

CFU describes live microorganism count. Read it alongside strain identity and the recommended age-appropriate daily amount.

How long are probiotics used in children?

Duration varies by study protocol, strain and product directions.

Are infant and child probiotics the same?

Infancy needs separate consideration for microbiota development and product suitability.

Related Vitallin products

Explore Vitallin formats for infants and children on the relevant pages:

Age group, daily serving and directions for Enteromax Sachets and Drops are clearly stated on their product pages.

Information Note

This content is for general information and educational purposes. It is not a substitute for medical advice, diagnosis or treatment. Consult your physician or the relevant healthcare professional for an assessment of your personal health.

This content is for general information. Seek healthcare advice for persistent diarrhoea, vomiting, fever, fluid loss or other significant symptoms. Medical treatment remains under healthcare supervision; probiotics are considered supportive.

References

  1. Chen et al. Lacticaseibacillus rhamnosus LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial. Frontiers in Nutrition. 2024;11:1479186. DOI: 10.3389/fnut.2024.1479186.
  2. Iwabuchi/Hiraku et al. Early probiotic supplementation of healthy term infants with Bifidobacterium longum subsp. infantis M-63. Nutrients. 2023;15:1402. DOI: 10.3390/nu15061402.
  3. Capeding et al. Safety, efficacy, and impact on gut microbial ecology of a Bifidobacterium longum subspecies infantis LMG11588 supplementation in healthy term infants. Frontiers in Nutrition. 2023;10:1319873. DOI: 10.3389/fnut.2023.1319873.